Tibet Rhodiola plans share buyback for employee incentive scheme

Tibet Rhodiola Pharmaceutical Holding Co., Ltd. announced a plan to repurchase its A-shares through centralized bidding transactions. The company intends to buy back shares worth between 17,000 yuan and 20,000 yuan, using its own funds. The repurchase price will not exceed 55 yuan per share, representing no more than 150% of the average trading price over the 30 trading days prior to the board's decision.

The primary purpose of this buyback is to implement equity incentive or employee stock ownership plans, aligning shareholder, company, and employee interests. The repurchase period is set for up to 12 months from the board's approval on December 18, 2025. Based on the maximum repurchase price, the company expects to buy back between 3.09m and 3.64m shares, representing approximately 0.96% to 1.13% of its total share capital.

The company's directors, senior management, controlling shareholders, and their concerted parties have confirmed no share sales within six months prior to the resolution date and no plans for share reductions in the next three or six months. The board has authorized the management to handle all related matters for the successful execution of the plan.